ScholarIQanswers from OpenAlex

Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells

PaperCitations, authors & open-access status

Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells have?

ScholarIQcitation count

Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells has 193 citations in the OpenAlex counts ScholarIQ stores.

When was Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells published?

ScholarIQyear

Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells has 2023 year in the ScholarIQ index.

What is the open-access status of Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells?

ScholarIQoa status

Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells has hybrid oa status in the ScholarIQ index.

What is the DOI of Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells?

ScholarIQdoi

The DOI for Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells is on the source record.

What is the PMID of Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells?

ScholarIQpmid

The PMID for Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells is on the source record.

What is the OpenAlex record for Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells?

ScholarIQopenalex

The OpenAlex for Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial